Abivax S.A.
ABVX.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | €426,191 | €422,908 | €117,991 | €441,269 |
| - Cash | €144,221 | €251,942 | €26,944 | €60,695 |
| + Debt | €97,361 | €55,464 | €39,161 | €53,446 |
| Enterprise Value | €379,331 | €226,430 | €130,208 | €434,020 |
| Revenue | €10,792 | €4,621 | €4,583 | €37 |
| % Growth | 133.5% | 0.8% | 12,286.5% | – |
| Gross Profit | €10,792 | €4,493 | €4,512 | -€119 |
| % Margin | 100% | 97.2% | 98.5% | -321.6% |
| EBITDA | -€167,682 | -€133,207 | -€53,315 | -€42,195 |
| % Margin | -1,553.8% | -2,882.6% | -1,163.3% | -114,040.5% |
| Net Income | -€176,242 | -€147,740 | -€60,740 | -€42,452 |
| % Margin | -1,633.1% | -3,197.1% | -1,325.3% | -114,735.1% |
| EPS Diluted | -2.8 | -3.43 | -3.18 | -2.75 |
| % Growth | 18.4% | -7.9% | -15.6% | – |
| Operating Cash Flow | -€154,072 | -€97,130 | -€65,579 | -€45,657 |
| Capital Expenditures | -€643 | -€265 | -€3,968 | -€1,642 |
| Free Cash Flow | -€154,715 | -€97,395 | -€69,547 | -€47,299 |